BMS-823778 is a novel, potent, orally bioavailable and selective inhibitor of 11-β-hydroxysteroid-dehydrogenase 1 (11βHSD-1). BMS-823778 is a potential therapeutic agent for type 2 diabetes mellitus (T2DM).

纯度：≥98%

CAS：1140898-87-8